Breaking News

Wheeler Bio, CRB Unveil New Oklahoma City Manufacturing Facility

35,000-square-foot facility for clinical drug substance manufacturing of antibodies and recombinant proteins.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Contract development and manufacturing organization (CDMO) Wheeler Bio and CRB, a provider of sustainable engineering, architectural, construction and consulting services to the life sciences industry, have started construction on a GMP drug substance facility that will support innovators seeking agile, small batch manufacturing services for their clinical trial materials (CTM). Wheeler is the newest member of Oklahoma City’s biotech hub. Housed in the ultra-modern Ziggurat building loc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters